Clinical trial
PET/CT Imaging Of Subjects With Lumbar Spinal Stenosis Or Carpal Tunnel Syndrome Using Amyloid-Reactive Peptide 124I-Evuzamitide
NCT06907849 is registered in ClinicalTrials.gov with University of Tennessee Graduate School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PET/CT Imaging Of Subjects With Lumbar Spinal Stenosis Or Carpal Tunnel Syndrome Using Amyloid-Reactive Peptide 124I-Evuzamitide
- Lead sponsor
- University of Tennessee Graduate School of Medicine
- Phase
- Phase 2
- Overall status
- Enrolling by invitation
- Start date
- May 22, 2025
- Completion date
- May 31, 2027
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac amyloidosis, carpal tunnel syndrome (cts), lumbar spinal stenosis